Detail akcie Zur Rose Group N online

Business Summary: DocMorris AG, formerly Zur Rose Group AG, is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. DocMorris operates at the healthcare, technology and e-commerce, with a primary focus on customer-centric digital healthcare and improving medication efficacy. core business is online pharmacy. In addition to prescription medicines (Rx), assortment features over-the-counter (OTC) and consumer health as well as beauty and personal care (BPC) products. Private labels, including nutritional supplements, painkillers, first-aid products and other OTC medicines. The Company's operates under brands such as PromoFarma, DoctiPharma, Apotal, Medpex and Teleclinic, among others
Financial Summary: BRIEF: For the six months ended 30 June 2025, DocMorris AG revenues increased 9% to SF541.5M. Net loss increased 62% to SF61.6M. Revenues reflect Germany segment increase of 9% to SF508M, Europe segment increase of 3% to SF33.5M, Germany segment increase of 9% to SF508M, Europe segment increase of 3% to SF33.5M. Higher net loss reflects Other Operating Expenses increase of 25% to SF103M (expense), Finance income decrease of 96% to SF590K (income).